Showing results (271-280 of 320) with videos related to

Sort By:
Pageof 32
Biomolecules|March 28, 2024
Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 LigandsSrijana Upadhyay, Amanuel Esayas Hailemariam, Fuada Mariyam, et al.
Investigational New Drugs|January 4, 2011
Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in ratsPius Maliakal, Maen Abdelrahim, Umesh T Sankpal, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2013
Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's diseaseBriana R De Miranda, James A Miller, Ryan J Hansen, et al.
Cancer Research Communications|May 18, 2022
Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal AdenocarcinomaMehrdad Zarei, Rupesh Shrestha, Sneha Johnson, et al.
Molecular Immunology|June 6, 2018
A novel diindolylmethane analog, 1,1-bis(3'-indolyl)-1-(p-chlorophenyl) methane, inhibits the tumor necrosis factor-induced inflammatory response in primary murine synovial fibroblasts through a Nurr1-dependent mechanismMaryam F Afzali, Katriana A Popichak, Lindsey H Burton, et al.
Plos One|February 2, 2018
Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancerYating Cheng, Parisa Imanirad, Indira Jutooru, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 24, 2021
Single-cell RNA Sequencing Reveals How the Aryl Hydrocarbon Receptor Shapes Cellular Differentiation Potency in the Mouse ColonYongjian Yang, Daniel Osorio, Laurie A Davidson, et al.
Transcription|July 12, 2025
Orphan nuclear receptor transcription factors as drug targetsStephen Safe, Arafat R Oany, Wai Ning Tsui, et al.
Metabolites|March 26, 2025
A Chalcone Synthase-like Bacterial Protein Catalyzes Heterocyclic C-Ring Cleavage of Naringenin to Alter Bioactivity Against Nuclear Receptors in Colonic Epithelial CellsEbru Ece Gülşan, Farrhin Nowshad, Meredith Davis Leigh, et al.
The Prostate|April 5, 2012
Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancerUmesh T Sankpal, Maen Abdelrahim, Sarah F Connelly, et al.
Pageof 32